TrialCirculation2014

Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial.

Michael J Koren et al.PubMed ↗Publisher ↗

No numbers read from the abstract.